Leadership & Pay ·
Scilex Holding Company held its 2026 Annual Meeting of Stockholders on June 24, 2026
SCLXScilex Holding Co
Scilex Holding Company held its 2026 Annual Meeting of Stockholders on June 24, 2026. Stockholders representing 100% of Series A Preferred Stock and approximately 63.5% of Common Stock were present. Nominee Dorman Followwill was elected as a Class I director. Shareholders ratified the appointment of BPM LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. Additionally, stockholders approved an amendment to the 2022 Equity Incentive Plan to increase the number of authorized shares to 2,765,789. Scilex Holding Company is a pharmaceutical company.